Showing 4,061 - 4,080 results of 4,870 for search '"pharmacy"', query time: 0.06s Refine Results
  1. 4061
  2. 4062
  3. 4063
  4. 4064
  5. 4065
  6. 4066
  7. 4067

    Advancements in Managing Anthracycline-Induced Cardiotoxicity: Insights from Interventional Clinical Trials by Zhao M, Zhang X, Zhou D, Song J

    Published 2025-01-01
    “…Mei Zhao,1 Xiaohong Zhang,1 Dongyang Zhou,2 Junxian Song3– 5 1Department of Pharmacy, Peking University People’s Hospital, Beijing, People’s Republic of China; 2Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK; 3Department of Cardiology, Peking University People’s Hospital, Beijing, People’s Republic of China; 4Beijing Key Laboratory of Early Prediction and Intervention of Acute Myocardial Infarction, Peking University People’s Hospital, Beijing, People’s Republic of China; 5Center for Cardiovascular Translational Research, Peking University People’s Hospital, Beijing, People’s Republic of ChinaCorrespondence: Junxian Song, Department of Cardiology, Peking University People’s Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, People’s Republic of China, Email sjx221@163.comPurpose: Anthracycline-induced cardiotoxicity (AIC) is a significant complication in cancer treatment, impacting long-term health outcomes. …”
    Get full text
    Article
  8. 4068
  9. 4069
  10. 4070
  11. 4071
  12. 4072
  13. 4073
  14. 4074
  15. 4075

    The mystery of methylene blue and its role in managing post-cardiac surgery vasoplegic shock by Mohamed Elbayomi, Oliver Dewald, Presheet Pathare, Markus Kondruweit, Rene Tandler, Michael Weyand, Christian Heim

    Published 2025-12-01
    “…The incidence of vasoplegic syndrome was 7.2% (n = 200). Pharmacy records identified 84 patients (group 1, MB group) who received methylene blue and 116 patients (group 2, Control group) who didn’t receive the drug. …”
    Get full text
    Article
  16. 4076
  17. 4077

    How the Suboxone Education Programme presented as a solution to risks in the Canadian opioid crisis: a critical discourse analysis by Quinn Grundy, Fiona Webster, Daniel Z Buchman, Sheryl Spithoff, Ross E G Upshur, Abhimanyu Sud, Matthew Strang

    Published 2022-07-01
    “…Within this context, this study examined how the ‘Suboxone Education Programme’, developed and delivered by a pharmaceutical company as part of a federally regulated risk management program, was presented as a solution to various kinds of risks relating to opioid use in public documents from medical institutions across Canada.Setting These documents were issued during the Canadian opioid crisis, a time when the involvement of industry in health policy was being widely questioned given industry’s role in driving the overprescribing of opioid analgesics and contributing to population-level harms.Design A critical discourse analysis of 69 documents collected between July 2020 and May 2021 referencing the Suboxone Education Program spanning 13 years (2007–2021) from medical, nursing and pharmacy institutions sourced from every Canadian province and territory. …”
    Get full text
    Article
  18. 4078
  19. 4079
  20. 4080

    DIVERSITY OF THE PUMPKIN COLLECTION AND ITS HEREDITARY POTENTIAL. RESULTS AND PROSPECTS OF BREEDING PRACTICE by A. G. Elatskova

    Published 2019-10-01
    “…It is widely used by national cuisines in many countries and utilized as raw material for canning industry and in pharmacy to prepare drugs. The Kuban Experiment Station of VIR, where the collection of pumpkin genetic resources is maintained and regenerated for long-term storage in the genebank, conducts comprehensive research work to analyze the genetic diversity of pumpkin accessions and disclose the potential of its hereditary variation.Objective. …”
    Get full text
    Article